Loading company…
Riskpilot
← Back to search
Sign in
Get full access
La Roar Life Science ApS
APS
Active
CVR 39379775
Violvej 25
Manufacture of other food products n.e.c. · NACE 1089
Est. 2018
1 employees
la-roar.com
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 426K
+7% vs 2024
EBITDA margin
99.8%
+49% vs 2024
Equity ratio
-100.2%
Financial strength
Net profit 2025
DKK 361K
+76% vs 2024
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
DKK 426K
+7%
EBITDA
DKK 425K
+49%
Net profit
DKK 361K
+76%
Total assets
DKK 498K
-10%
Equity
DKK -498K
+42%
Employees
1
—
Company information
Legal name
La Roar Life Science ApS
CVR number
39379775
Legal form
Anpartsselskab
NACE code
1089 · Manufacture of other food products n.e.c.
Founded
1. marts 2018
Share capital
DKK 105.556
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen alene
Company purpose
Virksomhedens formål er at udvikle og sælge kosttilskud.
Contact
Address
Violvej 25
Phone
+4542836223
Email
tine.stampe@la-roar.com
Website
la-roar.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of other food products n.e.c.
Companies in Gentofte
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
-92
-64
-4
398
426
Staff expenses
-137
-333
-232
-112
-1
EBITDA
-229
-397
-235
286
425
Depreciation & amort.
-92
-92
-27
-0
-0
EBIT
-321
-489
-262
286
425
Net financials
-28
-47
-77
-81
-64
Profit before tax
-349
-537
-339
205
361
Tax
-0
-0
-0
-0
-0
Net profit
-349
-537
-339
205
361
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
511
706
581
554
498
Equity
-189
-726
-1.065
-859
-498
Long-term debt
0
0
0
0
0
Short-term debt
700
1.432
1.645
1.413
996
Total debt
700
1.432
1.645
1.413
996
Financial ratios
5-year trend
EBITDA margin
99.8%
This company
15.8%
Market median
+532% vs market
2021
2025
Equity ratio
-100.2%
This company
38.2%
Market median
-362% vs market
2021
2025
Return on equity
36115100.0%
This company
18.4%
Market median
+196277617% vs market
2021
2025
Net profit margin
84.7%
This company
8.1%
Market median
+946% vs market
2021
2025
Asset turnover
0.86×
This company
1.12×
Market median
+23% vs market
2021
2025
Debt / equity
2.00×
This company
0.62×
Market median
-223% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
PS
Peter Stampe
Management
Management
2021
TS
Tine Stampe
Management
Management
2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
P. Stampe Holding ApS
Company
90–99.99%
90–99.99%
2020
Mexico City Holding ApS
Company
10–14.99%
10–14.99%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Mexico City Holding ApS
La Roar Life Science ApS
(this company)
Board network connections
Board members of La Roar Life Science ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Peter Stampe
Management
0 companies
Tine Stampe
Management
0 companies